Epidemiology Department, Epiconcept, Paris, France.
Direction des maladies infectieuses, Santé Publique France, Paris, France.
Euro Surveill. 2021 Jan;26(4). doi: 10.2807/1560-7917.ES.2021.26.4.1900762.
IntroductionPERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).AimThis observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity.MethodsWe developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites' annual incidences by dividing case numbers by the catchment populations.ResultsFrom December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0-11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700-4,925; IQR: 720) and 39 weeks (range: 25-42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway.ConclusionsIncidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.
介绍PERTINENT 是一个在六个欧盟/欧洲经济区国家(37 家医院,7 个地点)住院患有百日咳的婴儿的主动监测系统。目的本观察性研究旨在估计 2016 年至 2018 年每个地点的百日咳年发病率以及 2017 年至 2018 年的相应趋势。描述了百日咳病例,包括其严重程度。方法我们制定了一个通用的方案和实验室指南,以协调各地点的做法。病例为通过 PCR 或培养检测为阳性的住院婴儿。各站点收集人口统计学、临床、实验室数据、疫苗接种状况以及风险/保护因素。我们通过将病例数除以集水区人口来估计各站点的年发病率。结果从 2015 年 12 月至 2018 年 12 月,我们确定了 469 例病例(247 名男性;53%)。中位年龄、出生体重和胎龄分别为 2.5 个月(范围:0-11.6;四分位距(IQR):2.5)、3280 克(范围:700-4925;IQR:720)和 39 周(范围:25-42;IQR:2)。30 例(6%)表现不典型,仅咳嗽或发绀,或无百日咳样症状。在 330 例有信息的病例中,83 例(25%)被收入重症监护病房,其中包括 5 名因年龄太小而无法接种疫苗而死亡的婴儿。2018 年与 2017 年的发病率比值分别为捷克共和国 1.43(p=0.468)、加泰罗尼亚 0.25(p=0.002)、法国 0.71(p=0.034)、爱尔兰 0.14(p=0.002)、意大利 0.63(p=0.053)、纳瓦拉 0.21(p=0.148)和挪威 0.0(p=0.449)。结论除一个地点外,2017 年至 2018 年期间,所有地点的发病率似乎都有所下降。加强欧洲住院百日咳的监测对于监测百日咳流行病学和疾病负担至关重要。